713 related articles for article (PubMed ID: 8590162)
1. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
Poynard T; Lemaire M; Agostini H
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):661-5. PubMed ID: 8590162
[TBL] [Abstract][Full Text] [Related]
2. [Double-blind controlled-clinical trials of lansoprazole in the treatment of peptic ulcer].
Ogawa N
Nihon Rinsho; 1992 Jan; 50(1):68-73. PubMed ID: 1347332
[TBL] [Abstract][Full Text] [Related]
3. Bedtime administration of lansoprazole does not modify its greater efficacy vs ranitidine in the acute and long-term treatment of duodenal ulcer. Results from a multicentre, randomised, double blind clinical trial.
Russo A; Dattilo M
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):312-9. PubMed ID: 9476183
[TBL] [Abstract][Full Text] [Related]
4. Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group.
Feldman M; Harford WV; Fisher RS; Sampliner RE; Murray SB; Greski-Rose PA; Jennings DE
Am J Gastroenterol; 1993 Aug; 88(8):1212-7. PubMed ID: 8101695
[TBL] [Abstract][Full Text] [Related]
5. Double-blind comparison of lansoprazole, ranitidine, and placebo in the treatment of acute duodenal ulcer. Lansoprazole Study Group.
Lanza F; Goff J; Scowcroft C; Jennings D; Greski-Rose P
Am J Gastroenterol; 1994 Aug; 89(8):1191-200. PubMed ID: 8053433
[TBL] [Abstract][Full Text] [Related]
6. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
[TBL] [Abstract][Full Text] [Related]
7. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
Florent C
Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
[TBL] [Abstract][Full Text] [Related]
8. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
Eriksson S; Långström G; Rikner L; Carlsson R; Naesdal J
Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
[TBL] [Abstract][Full Text] [Related]
9. Lansoprazole: a comprehensive review.
Zimmermann AE; Katona BG
Pharmacotherapy; 1997; 17(2):308-26. PubMed ID: 9085323
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of lansoprazole (30 mg) and omeprazole (20 mg) in the treatment of duodenal ulcer. A multicenter double-blind comparative trial].
Petite JP; Slama JL; Licht H; Lemerez M; Coste T; Andrieu J; Grimaud JC; Julien H; Dupuis J; Sallerin V
Gastroenterol Clin Biol; 1993; 17(5):334-40. PubMed ID: 8349067
[TBL] [Abstract][Full Text] [Related]
11. Triple therapy with ranitidine or lansoprazole in the treatment of Helicobacter pylori-associated duodenal ulcer.
Lazzaroni M; Bargiggia S; Bianchi Porro G
Am J Gastroenterol; 1997 Apr; 92(4):649-52. PubMed ID: 9128316
[TBL] [Abstract][Full Text] [Related]
12. [Comparison between ranitidine, famotidine, and omeprazole in the treatment of bleeding duodenal ulcer].
Maculotti L; Pradella P
Minerva Chir; 1995 Mar; 50(3):279-81. PubMed ID: 7659265
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of duodenal ulcer with famotidine].
Schütze K; Hentschel E; Reichel W; Kerstan E
Wien Med Wochenschr; 1987 Sep; 137(17):409-11. PubMed ID: 2891224
[TBL] [Abstract][Full Text] [Related]
14. Prevention of recurrence of oesophageal stricture, a comparison of lansoprazole and high-dose ranitidine.
Swarbrick ET; Gough AL; Foster CS; Christian J; Garrett AD; Langworthy CH
Eur J Gastroenterol Hepatol; 1996 May; 8(5):431-8. PubMed ID: 8804870
[TBL] [Abstract][Full Text] [Related]
15. [Famotidine versus ranitidine in the acute treatment of duodenal ulcer. A multicenter comparative study in Germany].
Simon B; Dammann HG; Jakob G; Miederer SE; Müller P; Ottenjann R; Paul F; Scholten T; Schütz E; Seifert E
Z Gastroenterol; 1985 Feb; 23(2):47-51. PubMed ID: 2865859
[TBL] [Abstract][Full Text] [Related]
16. [Comparative efficacy of famotidine and ranitidine in the treatment of acute-phase duodenal ulcer. A French comparative therapeutic trial].
Delvaux M; Hagège CG; Ribet A
Gastroenterol Clin Biol; 1989 Dec; 13(12):1055-9. PubMed ID: 2696659
[TBL] [Abstract][Full Text] [Related]
17. Famotidine vs ranitidine h.s. in acute duodenal ulcer. A multicentre endoscopic trial.
Bianchi Porro G; Lazzaroni M; Barbara L; Corinaldesi R; Blasi A; Mangiameli A; Capurso L; Koch M; Cheli R; Bovero E
Ital J Gastroenterol; 1991 Feb; 23(2):65-9. PubMed ID: 1747505
[TBL] [Abstract][Full Text] [Related]
18. A multicenter, randomized, double-blind study comparing once-daily bedtime administration of famotidine and ranitidine in the short-term treatment of active duodenal ulcer.
Alcalá Santaella R; Guardia J; Pajares J; Pique J; Pita L; Alvárez E; Castellanos P; Guarner L; Ortiz J; Pesquera R
Hepatogastroenterology; 1989 Jun; 36(3):168-71. PubMed ID: 2666293
[TBL] [Abstract][Full Text] [Related]
19. Pantoprazole and ranitidine in the treatment of acute duodenal ulcer. A multicentre study.
Schepp W; Classen M
Scand J Gastroenterol; 1995 Jun; 30(6):511-4. PubMed ID: 7569755
[TBL] [Abstract][Full Text] [Related]
20. Effects of ranitidine on quality of gastric ulcer healing compared with famotidine: a randomized, controlled, multicenter trial.
Higuchi K; Watanabe T; Tominaga K; Shiba M; Nakagawa K; Uno H; Kitada K; Satoh H; Chono S; Uchida T; Fujiwara Y; Arakawa T
Int J Clin Pharmacol Res; 2005; 25(4):187-94. PubMed ID: 16402635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]